synergy pharmaceuticals seeking alpha

And Trulance has been very consistent since launch regarding source of dragon ball z episode 274 business, 50 of new prescriptions are new patients.
So as we said also during the September business update call is that come the first quarter early next year, we will provide further detail or guidance regarding our SG A expense and format factory key we expect to do that.
However, we view them as an important resource for bloggers and journalists, and are excited to contribute to the democratization of financial information on the Internet.And the results are evident within the prescription data, which we will discuss a little bit later.Troy Hamilton It's gastroenterologists.So we expect that to continue for a period of time.As a reminder, the company currently recognizes revenues based on prescription sales.A question-and-answer session will follow the formal presentation.As I mentioned before, we're really starting to see that momentum pick up in terms of access, which of course is going to be a benefit in terms of uptick as well.So now I'd like to provide an update on our key metrics that demonstrate that demand I just mentioned.We have the product, the strategy and the team to ensure continued success.Thank you, you may begin.Tim Chiang And Troy, maybe just a follow-up to that and we've all been tracking the prescriptions of course and it seems like, we're starting to see this uptick just recently.There is this increase in terms of the 90-day prescriptions, but also I think it might tie back to our product profile as well.For healthcare professionals, we are continuing to drive awareness, trial and adoption of Trulance.So our remit has always be to optimize to maximize the value Trulance by setting it up for launch success and then executing, and that's what we're doing.
Bill Tanner Completely understanding that it's early days in the launch and you don't want to make too much out of the numbers, but if I look at the numbers of prescriptions and the numbers of prescribers, it looks like that it's not really changing.
Executives, gem Hopkins - VP of IR and Corporate Communications.

Does that makes sense?This gives us flexibility to focus spend on the launch period and driving demand in growing revenue.Troy Hamilton, thank you, Gary.Troy Hamilton John, this is Troy.In addition to that the large PBM, Prime Therapeutics has removed the prior authorization for the majority of their Blue Cross Blue Shield plants across the country and this will be extended throughout 2018.Is there something that doctors are finally starting to get with trulance or do you see this progression continuing through year end and into 18?We have made really good progress with Medicare Part D and managed Medicaid as well.